Taken together, these data suggest that, in addition to the intracellular manner, ELAVL3 can be released in EVs and induce neuroendocrine differentiation of recipient adenocarcinoma cells, thereby propagating the phenotype via an intercellular mechanism. Here, ELAVL3 is linked to adenocarcinoma.